Viewing data from:

CHYMODIACTIN

BLA

CHYMOPAPAIN | B018663 | DISCURE MEDICAL, LLC

2 products0 Purple Book patents

Biologic LOENo LOE data

No exclusivity dates or listed patents found in Purple Book

Purple Book Patents

No listed patents in Purple Book.

PTAB Proceedings

No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board

Patent Reexaminations

No ex parte or inter partes reexamination proceedings found at USPTO

Hatch-Waxman Litigation

No ANDA patent litigation cases (NOS 835) matched from PACER

Citizen Petitions

No FDA citizen petitions matched from Regulations.gov

Clinical Trials

No clinical trials found on ClinicalTrials.gov for this drug

Purple Book (Biologics)

BLA 18663 | 2 presentations

351(a) ReferenceLicensedCDERFor Injection

Proper Name

chymopapain

Applicant

DisCure Medical, LLC

Approval Date

10-Nov-82

10,000UNITS — Single-Dose Vial (Intrathecal)

4,000UNITS — Single-Dose Vial (Intrathecal)

Source: FDA Purple Book (purplebooksearch.fda.gov).

Products (2)

Sort:

#001 — 10,000 UNITS/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**

▴

INJECTABLE;INJECTION | Approved: 1982-11-10 00:00:00

No patent or exclusivity listings for this strength.

#002 — 4,000 UNITS/VIAL

▾

INJECTABLE;INJECTION | Approved: 1982-11-10 00:00:00